Skip to main content
. 2010 Nov 9;5(11):e15378. doi: 10.1371/journal.pone.0015378

Table 1. Clinical data of malignant fibrous histiocytomas.

Sample Sample origin Patient age/sex Diagnosis MFH Subtype Grade1 Primary tumour location Size (cm)2 Metastasis (months)3 Status Follow-up (months)4
MFH1 Rec 87/M MFH Myxofibrosarcoma 4 Lower arm 5 48 DD 50
MFH2x Rec 71/M MFH Spindle and pleomorphic 4 Upper trunk 19 4 DD 15
MFH4 Prim 77/M MFH Spindle and pleomorphic 4 Upper arm 15 MD DD 3
MFH7 Prim 68/M MFH Spindle and pleomorphic 4 Upper leg 6 NM DOC 74
MFH8 Met 76/M MFH Spindle and pleomorphic 4 Knee5 6 15 DD 27
MFH9 Rec 57/F MFH Spindle and pleomorphic 4 Upper leg 3 NM DOC 346
MFH14 Prim 60/M MFH Spindle and pleomorphic 4 Knee 5.5 38 DD 82
MFH15 Prim 45/F MFH Pleomorphic with giant cells 4 Upper leg 20 6 DOC 6
MFH16 Rec 63/M MFH Myxofibrosarcoma 4 Upper trunk NA NM DOC 191
MFH18 Prim 61/M MFH Spindle and pleomorphic 4 Lower leg 18 16 DD 28
MFH19 Rec 71/F MFH Spindle and pleomorphic 4 Upper leg 5 NM NED 168
MFH20 Met 66/M MFH Spindle and pleomorphic 4 Upper leg6 18 17 DD 40
MFH21 Prim 73/F MFH Spindle and pleomorphic 4 Upper trunk 15 7 DD 21
MFH24 Prim 92/F MFH Spindle and pleomorphic 4 Upper leg 13 NM NED 159
MFH25 Prim 47/F MFH Myxofibrosarcoma 4 Upper leg 20 NM NED 182
MFH27 Rec 60/M MFH Spindle and pleomorphic 3 Knee 7.5 34 DD 181
MFH30 Prim 56/M MFH Spindle and pleomorphic 4 Retroperitoneum 15 MD DD 3
MFH34 Rec 79/F MFH Spindle and pleomorphic 3 Upper trunk 1.7 NM DOC 80
MFH36 Prim 75/M MFH Myxofibrosarcoma 4 Shoulder 20 7 DD 14
MFH42 Prim 71/M MFH Pleomorphic with giant cells 4 Upper arm 7.5 4 DD 22
MFH44 Rec 80/F MFH Spindle and pleomorphic 4 Upper leg 13 NM DOC 15
MFH45 Prim 69/F MFH Spindle and pleomorphic 4 Upper arm 14 NM NED 119
MFH46 Prim 82/M MFH Spindle and pleomorphic 4 Upper leg 11 NM NED 86
MFH47 Prim 56/M MFH Spindle and pleomorphic 4 Upper leg 7 7 DD 19
MFH48 Prim 63/M MFH Spindle and pleomorphic 4 Lower leg 7 MD DD 100
MFH53 Prim 69/F MFH Pleomorphic with giant cells 4 Retroperitoneum 18 5 DD 10
MFH54 Prim 45/M MFH Myxofibrosarcoma 4 Upper leg 20 6 DD 7
MFH56 Prim 75/F MFH Spindle and pleomorphic 4 Upper arm 10 9 NED 85
MFH59 Prim 68/M MFH Spindle and pleomorphic 4 Upper trunk 10.5 MD DD 7
MFH60 Prim 58/F MFH Pleomorphic 4 Upper arm 11 9 DD 58
MFH61 Prim 66/M MFH Myxofibrosarcoma 4 Upper leg 9.5 NM NED 74
MFH73x Rec 82/F MFH Spindle cell 4 Lower arm 7 14 DOC 59
MFH76x Prim 69/F MFH Spindle and pleomorphic 4 Lower leg 10 8 DD 18

Abbreviations: x, xenograft; Rec, recurrence; Prim, primary tumour; Met: metastasis; M, male; F, female; MFH, malignant fibrous histiocytoma; NA, not available; MD, metastasis at diagnosis; NM, no metastasis; DD, dead of disease; DOC, dead of other cause; NED, no evidence of disease;

1

Grading is based on a four-tiered system used in the Scandinavian Sarcoma Group (SSG);

2

Largest diameter of the tumour;

3

Time to first metastasis from diagnosis;

4

Time to last follow-up from diagnosis;

5

Metastasis located in the lung;

6

Metastasis located in the abdominal wall.